Upgrade to SI Premium - Free Trial

Truist Securities Reiterates Buy Rating on Eli Lilly (LLY)

April 17, 2026 9:57 AM
Truist Securities analyst Srikripa Devarakonda reiterated a Buy rating and $1,281.00 price target on Eli Lilly (NYSE: LLY).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments